-
Global Immunotherapy Drug Market Projected to Reach $467.4 Billion by 2030
15 Jan 2026 18:44 GMT
… for clinicians, researchers, and pharmaceutical stakeholders. The report provides insights … (CTLA-4), programmed cell death ligand 1 (PD-L1), and lymphocyte …
NOVARTIS AG
PFIZER INC.
SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD …
-
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
08 Dec 2025 18:18 GMT
… eczema clinical trials include OX40 ligand inhibitors, Interleukin 22 receptor …
III
OX40 ligand inhibitors
Subcutaneous
LP 0145
LEO Pharma
II
Interleukin … Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals, BioMimetix, Eli Lilly and …
-
How A Wall Street Analyst Started A $4 Billion Obesity Drug Company
14 Jan 2026 21:45 GMT
… he convinced the company, Ligand Pharmaceuticals, to not only license five … bidding war between Novo and Pfizer, which had earlier abandoned … safety concerns. In November, Pfizer won out, paying a whopping … about why Novo and Pfizer went after that company, …
-
<![CDATA[OX40/OX40 Ligand Target Offers Broader Acting Therapy for Atopic Dermatitis, With Raj Chovatiya, MD, PhD]]>
07 Nov 2025 04:54 GMT
… studied this OX40/OX40 ligand target. Therapies investigated include rocatinlimab … that the OX40 and OX40 ligand targeting molecules work.”
Relevant disclosures … , Incyte, LEO Pharma, L’Oréal, Nektar Therapeutics, Novartis, Opsidio, Pfizer Inc., Regeneron …
-
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
06 Nov 2025 12:00 GMT
… at www.ligand.com. About Ligand Pharmaceuticals Ligand is a … s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
20,170
18,574
LIGAND PHARMACEUTICALS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS …
-
<![CDATA[The OX40 Ligand Signaling Pathway and Atopic Dermatitis, With Shawn Kwatra, MD]]>
04 Nov 2025 00:31 GMT
… ‘Exploring the OX40 Ligand Signaling Pathway in Atopic … Pharmaceuticals, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte, Johnson & Johnson, Novartis, Pfizer, Regeneron Pharmaceuticals … Exploring the OX40 Ligand Signaling Pathway in Atopic …
-
Ligand to Participate in November Investor Conferences
30 Oct 2025 20:01 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … or Stifel representative. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
23 Oct 2025 11:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … available here.
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand to Host Investor Day on December 9, 2025
16 Oct 2025 11:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … the event here. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
09 Oct 2025 11:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … www.captisol.com. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
About
© 1995-2026